DY2 Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Cash GenerationConsistent positive operating and free cash flow provides durable internal funding for working capital, R&D and restructuring without immediate reliance on external capital. This cash generation supports deleveraging, funds execution of the return-to-growth plan and cushions near-term cyclical demand declines.
Innovation & Product PipelineRecent product clearances and AI-enabled diagnostics strengthen the company’s technology-led competitive position and increase stickiness of its installed base. Durable innovation supports higher-margin equipment sales, recurring software and consumable attach rates, and long-term differentiation versus peers.
Leadership & Restructuring FocusAdding a CFO with a track record in transformations, ERP integrations and debt reduction improves governance and execution capacity for the multi-year return-to-growth plan. Combined with a $120M restructuring target and early $20M OpEx savings, this should accelerate cost discipline and capital allocation improvements.
Bears Say
Elevated LeverageSignificantly higher leverage and a thin equity base constrain financial flexibility and increase refinancing and interest-rate risk. Negative ROE reflects equity erosion, making it harder to invest in growth or absorb further earnings volatility without material balance-sheet repair or equity issuance.
Sustained UnprofitabilityPersistent operating losses despite reasonable product gross margins indicate structural operating inefficiencies and mix pressure. Continued unprofitability erodes retained earnings, risks dividend sustainability, and requires sustained margin restoration to convert revenues into durable shareholder value.
Demand Softness & Distributor DestockingOngoing dealer and distributor destocking produces lumpy equipment orders and suppresses consumable refill cycles, extending revenue recovery timelines. This structural channel weakness complicates forecasting, delays margin recovery and increases the risk that cost saves won’t fully offset lower volumes.
DENTSPLY SIRONA News
DY2 FAQ
What was DENTSPLY SIRONA’s price range in the past 12 months?
Currently, no data Available
What is DENTSPLY SIRONA’s market cap?
DENTSPLY SIRONA’s market cap is CHF1.72B.
When is DENTSPLY SIRONA’s upcoming earnings report date?
DENTSPLY SIRONA’s upcoming earnings report date is Jul 30, 2026 which is in 28 days.
How were DENTSPLY SIRONA’s earnings last quarter?
DENTSPLY SIRONA released its earnings results on May 05, 2026. The company reported $0.215 earnings per share for the quarter, missing the consensus estimate of $0.222 by -$0.006.
Is DENTSPLY SIRONA overvalued?
According to Wall Street analysts DENTSPLY SIRONA’s price is currently Undervalued.
Does DENTSPLY SIRONA pay dividends?
DENTSPLY SIRONA does not currently pay dividends.
What is DENTSPLY SIRONA’s EPS estimate?
DENTSPLY SIRONA’s EPS estimate is 0.28.
How many shares outstanding does DENTSPLY SIRONA have?
Currently, no data Available
What happened to DENTSPLY SIRONA’s price movement after its last earnings report?
DENTSPLY SIRONA reported an EPS of $0.215 in its last earnings report, missing expectations of $0.222. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of DENTSPLY SIRONA?
Currently, no hedge funds are holding shares in CH:DY2
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
DENTSPLY SIRONA Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
CHF11.05 (― Downside)
CHF11.05 (― Downside)
Insider Transactions
Bought Shares
Worth CHF417.6K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-31.33%
12-Months-Change
Fundamentals
Return on Equity
-41.21%
Trailing 12-Months
Asset Growth
-13.57%
Trailing 12-Months
Company Description
DENTSPLY SIRONA
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. The Wellspect Healthcare segment offers medical devices, including catheters for urinary retention and advanced irrigation systems to help people suffering from chronic or severe constipation. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.
DY2 Company Deck
DY2 Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a balanced mix of encouraging operational and financial actions alongside notable near-term challenges. Positives include improved operating cash flow, active deleveraging (≈$79–$80M debt retired), early cost savings (≈$20M OpEx reduction in Q1) and meaningful innovation launches (AI diagnostic aid with ~46% sensitivity improvement, dental MRI clearance, new endodontic tools). Management also maintained full-year guidance and highlighted distributor expansion and early commercial traction. Offsetting these are material constant-currency revenue declines (Q1 cc sales down 6.7%, down 4.5% excluding one-time items), significant margin compression (adjusted EBITDA down 430 bps; gross profit down 560 bps), softness in several key segments (OIS, EDS, IPS, CTS), tariff-related margin pressure, distributor destocking, and an expected ~$30M inventory sell-through headwind later in the year. Given the roughly balanced set of meaningful positives (cash, cost saves, innovation, distribution) and negatives (sales declines, margin pressure, macro/timing risks), the overall tone is cautiously constructive but realistic about near-term headwinds.View all CH:DY2 earnings summariesDY2 Net sales Breakdown
15.71% Equipment & Instruments
12.45% CAD/CAM
39.92% Essential Dental Solutions
6.17% Orthodontics
16.93% Implants & Prosthetics
8.83% Wellspect Healthcare
DY2 Stock 12 Month Forecast
Average Price Target
$11.05
Options Prices
Currently, No data available
---